Recently, workers' compensation courts have entered orders mandating that employers and their insurance carriers provide such pharmaceutical benefits. That practice will be quickly reversed if U.S. Attorney General Jeff Session convinces Congress otherwise in accordance with a letter Sessions recently sent to Congress.